Collaborations & Alliances
Related Searches:
Filter by:
271 - 285 of 1089 results
April 4, 2012
XmAb platform delivers another candidate for clinical development
Read More »
April 4, 2012
Phase III program in postmenopausal osteoporosis underway
Read More »
April 3, 2012
Will jointly develop and commercialize five Amgen monoclonal antibodies
Read More »
March 30, 2012
Aims to identify biomarkers for Sanofi compound
Read More »
March 30, 2012
Royalty invests $25 million for development of AML drug
Read More »
March 29, 2012
Asterand unit expands access to BioMAP Platform
Read More »
March 26, 2012
Will develop, supply and distribute alternative dosage form products
Read More »
March 22, 2012
Will develop Crohn's disease drug in U.S. and Europe
Read More »
March 21, 2012
Triggers $8.7 million milestone payment
Read More »
March 20, 2012
Heptares eligible to receive as much as $190 million plus royalties
Read More »
March 15, 2012
MAKScientific eligible to receive as much as $34 million
Read More »
March 14, 2012
To find compounds against respiratory and inflammatory targets
Read More »
March 13, 2012
All rights licensed to Pfizer will revert to Biocon
Read More »
March 12, 2012
The develop optimized conditions for bioreactor-based cultivation
Read More »
271 - 285 of 1089 results
